Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Dermatol Online J ; 29(2)2023 Apr 15.
Article in English | MEDLINE | ID: mdl-37220292

ABSTRACT

Herein, we present a patient with a lipidized fibrous histiocytoma, an underrecognized variant of dermatofibroma (cutaneous fibrous histiocytoma). Our patient presented with a nodule on the ankle that showed foamy histiocytes and hyalinized collagen bundles on histology. This case highlights a classic presentation and features of lipidized fibrous histiocytoma, raising further awareness of this distinctive variant of dermatofibroma that should be distinguished from xanthoma and xanthogranuloma.


Subject(s)
Histiocytoma, Benign Fibrous , Humans , Leg , Ankle Joint , Pruritus
2.
Dermatol Online J ; 29(2)2023 Apr 15.
Article in English | MEDLINE | ID: mdl-37220293

ABSTRACT

Wolf isotopic response describes the onset of a new dermatosis at the site of a previous, healed dermatosis, which is usually a herpes zoster infection. Fibroelastolytic papulosis is a poorly understood elastolytic condition defined by a loss of elastic fibers specific to the papillary dermis. The present report describes a case of fibroelastolytic papulosis with onset following herpes zoster infection. This association provides new evidence for an immunopathogenic origin for fibroelastolytic papulosis and further supports current theories of the pathogenesis of Wolf isotopic response.


Subject(s)
Herpes Zoster , Skin Diseases , Wolves , Animals , Elastic Tissue
3.
Dermatol Online J ; 27(1)2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33560789

ABSTRACT

Orf virus causes a self-limited infection in humans that resolves without scarring within 6-12 weeks. However, lesions in the immunocompromised can be progressive and disfiguring. The lesions frequently recur after treatment. To our knowledge, there are eleven published cases of these infections. We propose the name orf progressiva to call attention to this progressive, treatment-resistant entity. We present a 43-year-old male ranch owner with a history of renal transplantation who contracted an orf infection from his lamb. The infection recurred despite attempts at debridement, but achieved near complete resolution after treatment with imiquimod and valacyclovir. The histologic findings of orf progressiva are identical to the early stages of classic orf infection and are characterized by epithelial hyperplasia, intracytoplasmic eosinophilic inclusions, and an edematous, vascular dermis. There is no standard treatment for orf progressiva. Surgical excision has frequently resulted in rapid reoccurrence. Topical therapies such as imiquimod and cidofovir cream in combination with excision have been successful in some cases. Acyclovir or valacyclovir with imiquimod has been reported to be effective. Two patients achieved cure with imiquimod alone. We summarize these cases to prompt recognition of orf progressiva as a distinct clinical entity that requires treatment.


Subject(s)
Ecthyma, Contagious/immunology , Immunocompromised Host , Adult , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/therapeutic use , Ciprofloxacin/therapeutic use , Debridement , Drug Therapy, Combination , Ecthyma, Contagious/diagnosis , Ecthyma, Contagious/drug therapy , Ecthyma, Contagious/pathology , Humans , Imiquimod/therapeutic use , Kidney Transplantation , Male , Pseudomonas Infections/diagnosis , Pseudomonas Infections/drug therapy , Pseudomonas Infections/immunology , Pseudomonas Infections/pathology , Pseudomonas aeruginosa , Superinfection , Valacyclovir/therapeutic use
5.
SELECTION OF CITATIONS
SEARCH DETAIL